Key facts
- This page summarizes Marcus Schulz's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2023, 18:02.
Marcus Schulz - 01 Mar 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)
- Reporting relationship
- Chief Revenue Officer
- Issuer ticker
- BLFS
- Reported as of
- 01 Mar 2023
- Net transaction value
- -$20,543
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2023, 18:02:05 UTC
- Prior SEC filing
- 13 Feb 2023
- Next SEC filing
- 16 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marcus Schulz
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Marcus Schulz filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 03 Mar 2023.
Change
- Previous filing in this sequence was filed on 13 Feb 2023.
- Current net transaction value: -$20,543.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLFS
transaction
Common Stock
Sale
- Transaction value
- $20,543
- Shares
- -903
- Change %
- -2.1%
- Price
- $22.75
- Shares after
- 42,478
- Date
- 01 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.